(NASDAQ:CAPR) LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities...
Related Questions
What is the probability of a significant settlement or judgment that could materially impact CAPR's valuation?
How is the market expected to react in terms of short‑term price volatility and trading volume following this lawsuit announcement?
Could the lawsuit trigger any regulatory actions, insider trading restrictions, or changes in share liquidity that traders should be aware of?